z-logo
Premium
Microglial neurotransmitter receptors trigger superoxide production in microglia; consequences for microglial–neuronal interactions
Author(s) -
Mead Emma L.,
Mosley Angelina,
Eaton Simon,
Dobson Lucianne,
Heales Simon J.,
Pocock Jennifer M.
Publication year - 2012
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.2012.07659.x
Subject(s) - neurotransmitter receptor , metabotropic receptor , microglia , glutamate receptor , receptor , biology , neuroprotection , chemistry , microbiology and biotechnology , neuroscience , biochemistry , inflammation , immunology
J. Neurochem. (2012) 121 , 287–301. Abstract Microglia express three isoforms of the NADPH oxidase, Nox1, Nox2 and Nox4, with the potential to produce superoxide (O 2 ˙ − ). Microglia also express neurotransmitter receptors, which can modulate microglial responses. In this study, microglial activity of Nox1, Nox2 and Nox4 in primary rat cultured microglia or the rodent BV2 cell line were altered by microglial neurotransmitter receptor modulation. Glutamate, GABA or ATP triggered microglial O 2 ˙ − production via Nox activation. Nox activation was elicited by agonists of metabotropic mGlu3 receptors and by group III receptors, by GABA A but not GABA B receptors, and by purinergic P2X 7 or P2Y 2/4 receptors but not P2Y 1 receptors, and inhibited by metabotropic glutamate receptor 5 antagonists. The neurotransmitters also modulated Nox mRNA expression and NADPH activity. The activation of Nox by BzATP or GABA promoted a neuroprotective phenotype whilst the activation of Nox by glutamate promoted a neurotoxic phenotype. Taken together, these data indicate that microglial neurotransmitter receptors can signal via Nox to promote neuroprotection or neurotoxicity. This has implications for the subsequent neurotoxic profile of microglia when neurotransmitter levels may become skewed in neurodegeneration.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here